Earnings Per Share |
Basic earnings per share is computed based on the weighted-average number of shares of common stock outstanding during the period. Diluted earnings per share include the dilutive effect of stock options, restricted stock awards, and warrants. The following is a reconciliation of the basic and diluted earnings per share ("EPS") computations for both the numerator and denominator (in thousands, except per share data):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Thirteen Weeks Ended September 25, 2021 |
|
Thirty-nine Weeks Ended September 25, 2021 |
|
Earnings (Numerator) |
|
Shares (Denominator) |
|
Per Share Amount |
|
Earnings (Numerator) |
|
Shares (Denominator) |
|
Per Share Amount |
Net loss |
$ |
(32,524) |
|
|
168,440 |
|
|
$ |
(0.19) |
|
|
$ |
(44,879) |
|
|
116,945 |
|
|
$ |
(0.38) |
|
Dilutive effect of stock options and awards |
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
Dilutive effect of warrants |
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
Net loss per diluted common share |
$ |
(32,524) |
|
|
168,440 |
|
|
$ |
(0.19) |
|
|
$ |
(44,879) |
|
|
116,945 |
|
|
$ |
(0.38) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Thirteen Weeks Ended September 26, 2020 |
|
Thirty-nine Weeks Ended September 26, 2020 |
|
Earnings (Numerator) |
|
Shares (Denominator) |
|
Per Share Amount |
|
Earnings (Numerator) |
|
Shares (Denominator) |
|
Per Share Amount |
Net loss |
$ |
9,304 |
|
|
89,745 |
|
|
$ |
0.10 |
|
|
$ |
(10,537) |
|
|
89,673 |
|
|
$ |
(0.12) |
|
Dilutive effect of stock options |
— |
|
|
780 |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
Net loss per diluted common share |
$ |
9,304 |
|
|
90,525 |
|
|
$ |
0.10 |
|
|
$ |
(10,537) |
|
|
89,673 |
|
|
$ |
(0.12) |
|
Stock options and awards outstanding totaling 1,492,329 and 2,017,795 were excluded from the computation for the thirteen and thirty-nine weeks ended September 25, 2021, respectively, as they would have had an antidilutive effect under the treasury stock method. Warrants of 19,787,515 and 6,595,838 were excluded from the computation for the thirteen and thirty-nine weeks ended September 25, 2021, respectively, as they would have had an antidilutive effect under the treasury stock method. Stock options and awards outstanding totaling 7,632,030 and 6,991,911 were excluded from the computation for the thirteen and thirty-nine weeks ended September 26, 2020, respectively, as they would have had an antidilutive effect under the treasury stock method.
|